SB-11285

N/A

Report date: 2023/07/27 20:00:35
NME

Base Information

Drug NameSB-11285
Drug Alias NameSB-11285
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionStimulator of interferon genes stimulants
TargetsStimulator of interferon genes
Therapy Area/IndicationsSolid tumoursSquamous Cell Carcinoma of Head and NeckMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSpring Bank
China Registration ClassN/A

Develop Information

Active CompaniesInvoX Pharma Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursSquamous Cell Carcinoma of Head and NeckMelanoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A